Jinli Wang is currently pursuing a Master of Science in Epidemiology at Georgetown University, following the completion of her Doctor of Acupuncture with a concentration in Traditional Chinese Medicine at the AOMA Graduate School of Integrative Medicine. She also holds a Bachelor of Medicine degree from Guangzhou University of Chinese Medicine, China’s top institution for Traditional Chinese Medicine. At the end of 2024,  Jinli will undertake a postdoctoral position at the Beijing University of Chinese Medicine Shenzhen Hospital, where she will focus on clinical research in internal medicine and integrative approaches to cancer therapy.

Jinli’s research centers on the molecular mechanisms of cancer immunopathogenesis, with a particular focus on the role of long non-coding RNAs (lncRNAs) in immune cell plasticity. Her recent work, "Chemotherapy-mediated lncRNA-induced immune cell plasticity in cancer immunopathogenesis," investigates how lncRNAs modulate the immune response in the tumor microenvironment, with an emphasis on potential therapeutic strategies for enhancing anti-tumor immunity and overcoming drug resistance.

Jinli’s clinical experience includes her work as a clinical research physician at the First Affiliated Hospital of Jinan University, where she contributed to rehabilitation trials. In addition, she has held leadership roles, such as Vice President of the Chinese Student and Scholar Association at Georgetown University. Her interdisciplinary background in epidemiology, molecular biology, and Traditional Chinese Medicine positions her at the forefront of innovative research integrating modern and traditional approaches to cancer treatment.